HCV kinetic and modeling analyses indicate similar time to cure among sofosbuvir combination regimens with daclatasvir, simeprevir or ledipasvir

Journal of Hepatology

from Gastroenterology via xlomafota13 on Inoreader http://ift.tt/1T6cvb7
via IFTTT